164 related articles for article (PubMed ID: 36442643)
1. Demographic and laboratory differences seen between acute generalized exanthematous pustulosis and drug reaction with eosinophilia and systemic symptoms: A cross-sectional analysis.
Gallardo MA; Mallela T; Gilkey T; Himed S; Walker TD; Nusbaum KB; Korman A; Trinidad J; Chung C; Kaffenberger BH
J Am Acad Dermatol; 2023 May; 88(5):1142-1145. PubMed ID: 36442643
[No Abstract] [Full Text] [Related]
2. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with skin eruptions mimicking acute generalized exanthematous pustulosis.
Goto T; Kogure A; Kuwano Y
J Dermatol; 2022 Jan; 49(1):e16-e17. PubMed ID: 34626006
[No Abstract] [Full Text] [Related]
3. Overlapping acute generalized exanthematous pustulosis drug reaction with eosinophilia and systemic symptoms induced by a second dose of the Moderna COVID-19 vaccine.
Ikeda T; Yokoyama K; Kawakami T
J Dermatol; 2022 Dec; 49(12):e446-e447. PubMed ID: 35906789
[No Abstract] [Full Text] [Related]
4. Severe acute generalized exanthematous pustulosis (AGEP) induced by miconazole oral gel with overlapping features of drug reaction with eosinophilia and systemic symptoms (DRESS).
Tedbirt B; Viart-Commin MH; Carvalho P; Courville P; Tétart F
Contact Dermatitis; 2021 Jun; 84(6):474-476. PubMed ID: 33382118
[No Abstract] [Full Text] [Related]
5. Koebnerization of Hailey-Hailey disease into a cutaneous drug eruption of acute generalized exanthematous pustulosis associated with systemic symptoms.
Totonchy MB; McNiff JM; Bunick CG
J Cutan Pathol; 2016 Nov; 43(11):1031-1035. PubMed ID: 27433827
[TBL] [Abstract][Full Text] [Related]
6. Allopurinol-induced drug rash with eosinophilia and systemic symptoms mimicking acute generalized exanthematous pustulosis.
Huang YC; Shih PY; Chin SY; Chiang YY
J Dermatol; 2012 Dec; 39(12):1077-8. PubMed ID: 22901319
[No Abstract] [Full Text] [Related]
7. Recognition and Management of Severe Cutaneous Adverse Drug Reactions (Including Drug Reaction with Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis).
Owen CE; Jones JM
Med Clin North Am; 2021 Jul; 105(4):577-597. PubMed ID: 34059239
[TBL] [Abstract][Full Text] [Related]
8. Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore.
Lee HY; Chou D; Pang SM; Thirumoorthy T
Int J Dermatol; 2010 May; 49(5):507-12. PubMed ID: 20534083
[TBL] [Abstract][Full Text] [Related]
9. [The major SCAR syndromes].
Piérard GE; Lesuisse M; Piérard-Franchimont C
Rev Med Liege; 2017 Oct; 72(10):444-447. PubMed ID: 29058836
[TBL] [Abstract][Full Text] [Related]
10. Pustular-type drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to carbamazepine with systemic muscle involvement.
Matsuda H; Saito K; Takayanagi Y; Okazaki T; Kashima K; Ishikawa K; Kai Y; Takeo N; Hatano Y; Okamoto O; Fujiwara S
J Dermatol; 2013 Feb; 40(2):118-22. PubMed ID: 23216243
[TBL] [Abstract][Full Text] [Related]
11. Treatments for Severe Cutaneous Adverse Reactions.
Cho YT; Chu CY
J Immunol Res; 2017; 2017():1503709. PubMed ID: 29445753
[TBL] [Abstract][Full Text] [Related]
12. DRESS syndrome and acute generalized exanthematous pustulosis induced by antituberculosis medications and moxifloxacin: case report
.
Kim H; Bang ES; Lim SK; Lee JM
Int J Clin Pharmacol Ther; 2016 Oct; 54(10):808-15. PubMed ID: 27443659
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation and management of atypical and recalcitrant acute generalized exanthematous pustulosis.
Hadavand MA; Kaffenberger B; Cartron AM; Trinidad JCL
J Am Acad Dermatol; 2022 Sep; 87(3):632-639. PubMed ID: 32926975
[TBL] [Abstract][Full Text] [Related]
14. [CME. Severe cutaneous drug reaction].
Deuel J; Schaer D; Schmid-Grendelmeier P; Vallelian F
Praxis (Bern 1994); 2014 Oct; 103(21):1231-43. PubMed ID: 25305114
[No Abstract] [Full Text] [Related]
15. Skin tests in the work-up of cutaneous adverse drug reactions: A review and update.
Barbaud A; Castagna J; Soria A
Contact Dermatitis; 2022 May; 86(5):344-356. PubMed ID: 35122269
[TBL] [Abstract][Full Text] [Related]
16. DRESS and AGEP Reactions to Iodinated Contrast Media: A French Case Series.
Soria A; Amsler E; Bernier C; Milpied B; Tétart F; Morice C; Dezoteux F; Ferrier-Le Bouedec MC; Barbaud A; Staumont-Sallé D; Assier H;
J Allergy Clin Immunol Pract; 2021 Aug; 9(8):3041-3050. PubMed ID: 33757916
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.
Wei BM; Fox LP; Kaffenberger BH; Korman AM; Micheletti RG; Mostaghimi A; Noe MH; Rosenbach M; Shinkai K; Kwah JH; Phillips EJ; Bolognia JL; Damsky W; Nelson CA
J Am Acad Dermatol; 2024 May; 90(5):885-908. PubMed ID: 37516359
[TBL] [Abstract][Full Text] [Related]
18. Pustular Psoriasis and Acute Generalized Exanthematous Pustulosis.
Sussman M; Napodano A; Huang S; Are A; Hsu S; Motaparthi K
Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684041
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of severe drug hypersensitivity.
Dodiuk-Gad RP; Laws PM; Shear NH
Semin Cutan Med Surg; 2014 Mar; 33(1):2-9. PubMed ID: 25037253
[TBL] [Abstract][Full Text] [Related]
20. Paracetamol (Acetaminophen)-associated SJS, TEN, AGEP, and DRESS Syndromes - A Narrative Review.
Pakkir Maideen NM; Barakat IR; Jumale AH
Curr Drug Saf; 2024; 19(2):218-223. PubMed ID: 37151075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
